Detailed price information for Dyne Therapeutics Inc (DYN-Q) from The Globe and Mail including charting and trades.
The addition of these two rare diseases to the RUSP is a victory for American families and the nearly 1 in 500 newborns who ...
Solid Biosciences Inc. (NASDAQ:SLDB) is one of the stocks that will double in 2026. On December 4, Needham analyst Gil Blum ...
Scotland’s NHS can now offer givinostat to ambulant children with Duchenne muscular dystrophy, marking a step forward in care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback